Healthequity (NASDAQ:HQY) had its target price hoisted by Cantor Fitzgerald from $56.00 to $60.00 in a research report sent to investors on Wednesday morning. They currently have an overweight rating on the stock.

A number of other equities research analysts also recently issued reports on HQY. Zacks Investment Research raised shares of Healthequity from a hold rating to a buy rating and set a $58.00 price target on the stock in a research note on Wednesday, October 11th. BidaskClub downgraded shares of Healthequity from a hold rating to a sell rating in a research note on Wednesday, October 18th. Chardan Capital upped their price target on shares of Healthequity from $58.00 to $62.00 and gave the company a buy rating in a research note on Wednesday, December 6th. Citigroup began coverage on shares of Healthequity in a research note on Thursday, January 4th. They set a buy rating on the stock. Finally, JPMorgan Chase & Co. decreased their price target on shares of Healthequity from $52.00 to $51.00 and set an overweight rating on the stock in a research note on Wednesday, January 24th. Three analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. The stock presently has an average rating of Buy and an average price target of $57.17.

Healthequity (NASDAQ:HQY) opened at $49.93 on Wednesday. Healthequity has a 1-year low of $37.62 and a 1-year high of $55.31. The company has a market cap of $3,121.61, a price-to-earnings ratio of 67.47, a PEG ratio of 1.99 and a beta of 1.70.

Healthequity (NASDAQ:HQY) last released its earnings results on Tuesday, December 5th. The company reported $0.17 EPS for the quarter, topping the consensus estimate of $0.13 by $0.04. Healthequity had a net margin of 21.08% and a return on equity of 14.47%. The firm had revenue of $56.80 million for the quarter, compared to the consensus estimate of $55.27 million. During the same quarter in the previous year, the firm earned $0.10 earnings per share. The company’s quarterly revenue was up 31.0% compared to the same quarter last year. analysts anticipate that Healthequity will post 0.73 earnings per share for the current fiscal year.

In other Healthequity news, insider Jon Kessler sold 40,000 shares of the business’s stock in a transaction on Thursday, January 25th. The shares were sold at an average price of $49.47, for a total transaction of $1,978,800.00. Following the transaction, the insider now owns 485,000 shares in the company, valued at $23,992,950. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Ashley Dreier sold 12,000 shares of the business’s stock in a transaction on Monday, January 29th. The shares were sold at an average price of $52.00, for a total transaction of $624,000.00. Following the transaction, the vice president now owns 17,652 shares in the company, valued at approximately $917,904. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 371,426 shares of company stock worth $18,749,703. 29.00% of the stock is owned by insiders.

Hedge funds have recently bought and sold shares of the business. Zions Bancorporation bought a new position in Healthequity during the third quarter valued at $119,000. Catalyst Capital Advisors LLC bought a new position in Healthequity during the fourth quarter valued at $149,000. CIBC Asset Management Inc bought a new position in Healthequity during the third quarter valued at $208,000. 1st Global Advisors Inc. bought a new position in Healthequity during the second quarter valued at $213,000. Finally, Shelton Capital Management bought a new position in Healthequity during the second quarter valued at $217,000. Institutional investors and hedge funds own 98.20% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This piece was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece on another website, it was stolen and republished in violation of United States & international copyright legislation. The legal version of this piece can be accessed at https://www.thecerbatgem.com/2018/02/08/healthequity-hqy-price-target-raised-to-60-00.html.

About Healthequity

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Analyst Recommendations for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.